116 related articles for article (PubMed ID: 37382472)
1. Curcumin relieves arecoline-induced oral submucous fibrosis via inhibiting the LTBP2/NF-κB axis.
Zhang L; Tan J; Liu Y; Luo M
Oral Dis; 2024 May; 30(4):2314-2324. PubMed ID: 37382472
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
3. Curcumin relieves the arecoline-induced fibrosis of oral mucosal fibroblasts via inhibiting HIF-1α/TGF-β/CTGF signaling pathway: an
Zhang L; Tan J; Liu YP; Liu X; Luo M
Toxicol Res (Camb); 2021 May; 10(3):631-638. PubMed ID: 34141177
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hypoxia-inducible factor-1α in human buccal mucosal fibroblasts stimulated with arecoline.
Ho YC; Yang SF; Lee SS; Chang YC
J Formos Med Assoc; 2017 Jun; 116(6):484-487. PubMed ID: 28365254
[TBL] [Abstract][Full Text] [Related]
5. Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin.
Deng YT; Chen HM; Cheng SJ; Chiang CP; Kuo MY
Oral Oncol; 2009 Sep; 45(9):e99-e105. PubMed ID: 19457704
[TBL] [Abstract][Full Text] [Related]
6. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
7. Antifibrotic effect of curcumin in TGF-β 1-induced myofibroblasts from human oral mucosa.
Zhang SS; Gong ZJ; Li WH; Wang X; Ling TY
Asian Pac J Cancer Prev; 2012; 13(1):289-94. PubMed ID: 22502687
[TBL] [Abstract][Full Text] [Related]
8. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
9. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
10. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
Liao YW; Yu CC; Hsieh PL; Chang YC
J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor-1α expression in areca quid chewing-associated oral squamous cell carcinomas.
Lee SS; Tsai CH; Yang SF; Ho YC; Chang YC
Oral Dis; 2010 Oct; 16(7):696-701. PubMed ID: 20846156
[TBL] [Abstract][Full Text] [Related]
12. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts.
Ni WF; Tsai CH; Yang SF; Chang YC
Oral Oncol; 2007 Jul; 43(6):557-62. PubMed ID: 16996785
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast activating protein promotes the proliferation, migration, and activation of fibroblasts in oral submucous fibrosis.
Li M; Deng Z; Xie C; Chen J; Yuan Z; Rahhal O; Tang Z
Oral Dis; 2024 Apr; 30(3):1252-1263. PubMed ID: 37357365
[TBL] [Abstract][Full Text] [Related]
16. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids.
Chen CC; Huang JF; Tsai CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):604-14. PubMed ID: 7490793
[TBL] [Abstract][Full Text] [Related]
17. Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS).
Zhou L; Tan J; Dai Y; Zhu K; Xiao Y; Wu D; Wang Z; Tan Y; Qin Y
Drug Des Devel Ther; 2023; 17():3085-3101. PubMed ID: 37854130
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
Huang J; Zhang H; Fan X; Guo J
Oral Health Prev Dent; 2022 Jun; 20(1):339-348. PubMed ID: 35920886
[TBL] [Abstract][Full Text] [Related]
19. Arecoline inhibits epithelial cell viability by upregulating the apoptosis pathway: implication for oral submucous fibrosis.
Li M; Gao F; Zhou ZS; Zhang HM; Zhang R; Wu YF; Bai MH; Li JJ; Lin SR; Peng JY
Oncol Rep; 2014 May; 31(5):2422-8. PubMed ID: 24647969
[TBL] [Abstract][Full Text] [Related]
20. Egr-1 mediates low-dose arecoline induced human oral mucosa fibroblast proliferation via transactivation of Wnt5a expression.
Chen Q; Jiao J; Wang Y; Mai Z; Ren J; He S; Li X; Chen Z
BMC Mol Cell Biol; 2020 Nov; 21(1):80. PubMed ID: 33167868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
